Arcutis Biotherapeutics Clinical Site 19

Reno, Nevada 89509

0 studies enrolling now · 1 studies all time

What they study most

Seborrheic Dermatitis

Studies at this site

• Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM) — Completed